Most patients with advanced malignancy suffer bone metastases, which pose a significant challenge to orthopaedic services and burden to the health economy. This study aimed to assess adherence to the British Orthopaedic Oncology Society (BOOS)/British Orthopaedic Association (BOA) guidelines on patients with metastatic bone disease (MBD) in the UK. A prospective, multicentre, national collaborative audit was designed and delivered by a trainee-led collaborative group. Data were collected over three months (1 April 2021 to 30 June 2021) for all patients presenting with MBD. A data collection tool allowed investigators at each hospital to compare practice against guidelines. Data were collated and analyzed centrally to quantify compliance from 84 hospitals in the UK for a total of 1,137 patients who were eligible for inclusion.Aims
Methods
Malignancy and surgery are risk factors for venous thromboembolism (VTE). We undertook a systematic review of the literature concerning the prophylactic management of VTE in orthopaedic oncology patients. MEDLINE (PubMed), EMBASE (Ovid), Cochrane, and CINAHL databases were searched focusing on VTE, deep vein thrombosis (DVT), pulmonary embolism (PE), bleeding, or wound complication rates.Aims
Methods
Highly porous acetabular components are widely used in revision hip surgery. The purpose of this study is to compare the mid-term survivorship, clinical and radiological outcomes of a hemispherical cup (Stryker Tritanium Revision component) and a peripherally expanded cup (Zimmer TM modular component) in revision hip surgery. Between 2010 and 2017, 30 patients underwent revision hip replacement using a hemispherical cup and 54 patients using a peripherally expanded cup. The surgery was carried out by two arthroplasty surgeons, both fellowship-trained in revision hip surgery. Kaplan-Meier analysis was used to determine the survivorship of the components. Clinical outcomes were measured using the Oxford Hip Score. Radiographs were analysed for the presence of radiolucent lines in the DeLee and Charnley zones.Background
Methods
All Polyethylene Tibial components in Total Knee Arthroplasty have been in use for some years, studies showing equivalent results to Total Knee Arthroplasty (TKA) with metal-backed Tibial components at 10 years have shown no significant difference between the two on radiostereometric analysis and revision rates[1]. Post operative patient outcome data using standard metal-backed Tibial components is widely reported in the literature. This study is looking at patient outcomes following All-polyethylene tibial component TKA. We hypothesize that using standard patient outcome measures, an improvement comparable with that expected for metal-backed tibial component TKA will be shown with All-polyethylene tibial component TKA. Between August 2006 and August 2008, 229 all-polyethylene tibial component TKA were implanted at the elective orthopedic unit. The choice of implant was entirely dependent on surgeon's preference. Of the 229 patient's, 225 details were available for review, 27 did not wish to take part in the study and 1 patient died a year following surgery of an unrelated illness. The remaining 197 patients agreed to take part in the study. The patient's were contacted either in person or over the telephone and asked to completed questionnaires for standard knee scoring. These included: the Oxford Knee Score (OKS), the WOMAC Score and the SF-12 Score, both pre-operatively and post operatively.Objectives
Methods
Results: Subsequent second metastasis formation occurred at the tip of the nail compounded by pathological fracture. Salvage surgery was achieved in one case with a total femoral replacement and in the other by bi-columnar plating of the humerus with cement augmentation.
The most appropriate protocol for the biopsy of musculoskeletal tumours is controversial, with some authors advocating CT-guided core biopsy. At our hospital the initial biopsies of most musculoskeletal tumours has been by operative core biopsy with evaluation by frozen section which determines whether diagnostic tissue has been obtained and, if possible, gives the definitive diagnosis. In order to determine the accuracy and cost-effectiveness of this protocol we have undertaken a retrospective audit of biopsies of musculoskeletal tumours performed over a period of two years. A total of 104 patients had biopsies according to this regime. All gave the diagnosis apart from one minor error which did not alter the management of the patient. There was no requirement for re-biopsy. This protocol was more labour-intensive and 38% more costly than CT-guided core biopsy (AU$1804
Bone tumours are not common in the bones of the feet. We reviewed 10 years of referrals to the Leeds regional bone tumour registry between 1990 and 1999 which revealed twenty such tumours accounting for 5% of the total number of 341 bone tumours. The mean age of the patients was 32 years (range 2 yrs to 80 yrs). Men were affected more commonly than women (60% versus 40%). 40% affected the tarsal bones, 25% affected the hind foot, and 35 % affected the small tubular bones of the foot. 80% of tumours were benign. Malignant tumours accounted for only 20 % of all foot tumours and of these, 95% were primary tumours and only 5 % were metastases. Malignant tumours were found more frequently in the older population mean age (50 years). Bone tumour registries offer a reliable source of data to study rare neoplasms in a large population group.
Longer hip axis length (HAL) has been shown to be associated with the risk of hip fracture. We examined whether HAL is associated with hip fracture risk in elderly community dwelling women in England, unselected for osteoporosis. We undertook a case-controlled study of women aged ≥ 75 years enrolled to a large, randomised controlled study looking at the effect of a bisphosphonate, clodronate, in the prevention of hip fractures. Cases comprised those women who sustained a radiologically verified hip fracture during follow-up (median 3. 1 years). Two age, height and weight-matched controls were selected for each case. Baseline total hip bone mineral density (BMD) was measured using a Hologic 4500 QDR and the HAL was measured using the densitometer’s automated software. 92 of 4347 women (2. 1%) sustained a hip fracture, but two women had not received a baseline BMD assessment and were excluded, leaving 90 women with hip fractures and 180 matched controls. The mean age of the cases and controls was 81. 9 ± 4. 9 years. The mean hip BMD was significantly lower (0. 65 ± 0. 31 vs 0. 72 ± 0. 13, P<
0. 001) and the mean HAL was significantly longer in the hip fracture women than the controls (11. 1 ± 0. 6 vs 10. 9 ± 0. 6, P=0. 03). The increase in the HAL was significantly associated with the risk of hip fracture (Odds Ratio (OR) per 1 standard deviation increase was 1. 33, 95% CI 1. 02–1. 72; p=0. 03) remaining significant after adjustment for hip BMD (OR 1. 32, 95% CI 1. 01–1. 71; p=0. 04). An increase in hip axis length is associated with an increased risk of hip fracture in elderly English women independent of hip BMD, although the odds ratio appears somewhat lower than that reported in other studies.